The influence of silicon on the oxidation of Fe‐14% Cr and Fe‐28% Cr has been studied at high temperature, with particular emphasis on the development and nature of the healing SiO2 layer. In general, silicon is a less effective addition than aluminium to these alloys in improving oxidation resistance because SiO2 grows at a lower rate than α‐Al2O3. Hence, silicon is a less successful oxygen secondary getter and development of a complete healing layer of SiO2 is less rapid than that of α‐Al2O3 on a corresponding aluminium‐containing alloy. Nonetheless, the addition of only 1% Si to Fe‐28% Cr causes a marked reduction in the overall oxidation rate, particularly by facilitating development of the Cr2O3 scale. Precipitates of SiO2 form at the alloy/scale interface. These grow inwards and laterally until they eventually link up to establish a continuous healing layer at the interface after several hundred hours exposure at 1000°C. Similar features are observed for Fe‐14% Cr‐3% Si but the healing SiO2 layer develops after a much shorter time for Fe‐14% Cr‐10% Si, due to the high silicon availability. In every case, the healing layer has been shown to be amorphous SiO2. Although this phase is very protective during isothermal oxidation, it is a site of weakness during cooling and scale spallation is very extensive from specimens where the SiO2 is continuous, with failure occurring cohesively within that layer.
Ion implantation of silicon into Fe‐14% Cr and Fe‐28% Cr gives a reduced oxidation rate due to facilitation of a more rapid establishment of a Cr2O3 scale. Similar implantation of yttrium into the ternary alloys assists in development of the silicon‐containing oxide layer, possibly associated with an influence on the nucleation of the oxide precipitates in the early stages of exposure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.